MDA and AFM co-sponsored a symposium on neuromuscular gene therapy at the 2012 meeting of the American Society for Gene & Cell Therapy
Overcoming barriers to gene therapy — the delivery of therapeutic genes — to treat neuromuscular diseases was the topic of a symposium jointly sponsored by MDA and the Association Française Contre les Myopathies (French Association Against Myopathies, or AFM) at the 15th annual meeting of the American Society of Gene & Cell Therapy (ASGCT).
Winners with ALS, SMA and LGMD receive support to pursue postgraduate education
Three accomplished scholars determinedly pursuing their educations while living with neuromuscular disease are the first winners of the CMMS Deshae Lott Ministries outreach program scholarships.
“We were so impressed,” with the winning candidates, said Deshae Lott, 39, a teacher and minster from Bossier City, La., who founded the nonprofit that bears her name. “These three show great strength of...
Brice Carroll lives in Hot Springs, Ark. He has limb-girdle muscular dystrophy.
Ms. Wheelchair Michigan spreads message of self-advocacy and inclusion
In this issue: Cardiac risks seen in both type 2 MMD and limb-girdle type 2I ** People with myasthenia gravis frequently exhibit higher levels of anxiety